David Tepper

947 total citations
62 papers, 586 citations indexed

About

David Tepper is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Biomedical Engineering. According to data from OpenAlex, David Tepper has authored 62 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 4 papers in Biomedical Engineering. Recurrent topics in David Tepper's work include Heart Failure Treatment and Management (20 papers), Cardiac electrophysiology and arrhythmias (18 papers) and Cardiac Arrhythmias and Treatments (17 papers). David Tepper is often cited by papers focused on Heart Failure Treatment and Management (20 papers), Cardiac electrophysiology and arrhythmias (18 papers) and Cardiac Arrhythmias and Treatments (17 papers). David Tepper collaborates with scholars based in United States. David Tepper's co-authors include John C. Somberg, Vilma Torres, William H. Frishman, Eliot J. Lazar, Scott Harris, Dennis S. Miura, Miriam K. Aronson, Steven M. Greenberg, Wee Lock Ooi and David Flowers and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Cardiology and American Heart Journal.

In The Last Decade

David Tepper

59 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Tepper United States 12 471 79 73 64 42 62 586
Elizabeth Lee Lewandrowski United States 13 330 0.7× 31 0.4× 135 1.8× 83 1.3× 42 1.0× 28 557
AJ Camm United Kingdom 8 1.2k 2.5× 117 1.5× 48 0.7× 87 1.4× 38 0.9× 23 1.3k
G. Frangin France 7 1.1k 2.4× 100 1.3× 51 0.7× 77 1.2× 35 0.8× 9 1.2k
P D Batin United Kingdom 11 446 0.9× 28 0.4× 93 1.3× 89 1.4× 23 0.5× 15 537
J. S. Alpert United States 9 388 0.8× 90 1.1× 73 1.0× 123 1.9× 77 1.8× 22 642
J Benotti United States 8 532 1.1× 96 1.2× 60 0.8× 158 2.5× 38 0.9× 8 674
Joan G. Meeder Netherlands 16 678 1.4× 41 0.5× 159 2.2× 126 2.0× 30 0.7× 40 809
D G Julian United Kingdom 10 902 1.9× 109 1.4× 90 1.2× 120 1.9× 38 0.9× 27 1.1k
C. Torp‐Pedersen Denmark 11 358 0.8× 28 0.4× 34 0.5× 47 0.7× 41 1.0× 23 475
J. R. Hampton United Kingdom 11 600 1.3× 45 0.6× 32 0.4× 89 1.4× 40 1.0× 31 809

Countries citing papers authored by David Tepper

Since Specialization
Citations

This map shows the geographic impact of David Tepper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Tepper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Tepper more than expected).

Fields of papers citing papers by David Tepper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Tepper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Tepper. The network helps show where David Tepper may publish in the future.

Co-authorship network of co-authors of David Tepper

This figure shows the co-authorship network connecting the top 25 collaborators of David Tepper. A scholar is included among the top collaborators of David Tepper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Tepper. David Tepper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tepper, David, et al.. (2010). Dynamic Cardiovascular Risk Assessment in Elderly People. Congestive Heart Failure. 16(4). 189–190. 1 indexed citations
2.
Tepper, David, et al.. (2010). Patient Expectations From Implantable Defibrillators to Prevent Death in Heart Failure. Congestive Heart Failure. 16(4). 189–189. 2 indexed citations
3.
Harris, Scott R., et al.. (2009). Extended Mechanical Circulatory Support With a Continuous‐Flow Rotary Left Ventricular Assist Device. Congestive Heart Failure. 16(2). 85–85. 6 indexed citations
4.
Tepper, David, et al.. (2008). Characterization and Prognostic Value of Persistent Hyponatremia in Patients With Severe Heart Failure in the ESCAPE Trial. Congestive Heart Failure. 14(1). 46–46. 10 indexed citations
5.
Harris, Scott, et al.. (2008). Pioglitazone and Heart Failure: Results From a Controlled Study in Patients With Type 2 Diabetes Mellitus and Systolic Dysfunction. Congestive Heart Failure. 14(6). 335–335. 3 indexed citations
6.
Harris, Scott, et al.. (2008). Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation: A Phase 3, Randomized, Placebo‐Controlled Trial. Congestive Heart Failure. 14(4). 226–226. 8 indexed citations
7.
Tepper, David, et al.. (2007). Rosiglitazone and Heart Failure: The Controversy and Clinical Implications. Congestive Heart Failure. 13(5). 293–295. 1 indexed citations
8.
Somberg, John C., et al.. (2004). Enhancement of Myocardial Vulnerability by Atrial Fibrillation. American Journal of Therapeutics. 11(1). 33–43. 21 indexed citations
9.
Tepper, David. (2003). Clinical Outcomes in Patients on Beta‐Blocker Therapy Admitted With Worsening Chronic Heart Failure. Congestive Heart Failure. 9(2). 106–107. 1 indexed citations
10.
Tepper, David, et al.. (1992). Adenosine and its cardiovascular effects. American Heart Journal. 123(5). 1324–1328. 38 indexed citations
11.
Dick, Michael, et al.. (1991). Digitalis Intoxication Recognition and Management. The Journal of Clinical Pharmacology. 31(5). 444–447. 9 indexed citations
12.
Frishman, William H., et al.. (1990). Betaxolol: A New Long‐Acting Beta1‐Selective Adrenergic Blocker. The Journal of Clinical Pharmacology. 30(8). 686–692. 8 indexed citations
13.
Frishman, William H., Wee Lock Ooi, David Tepper, et al.. (1990). Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: The Bronx Aging Study. The American Journal of Cardiology. 66(5). 533–537. 120 indexed citations
14.
Somberg, John C., et al.. (1988). Propafenone: A new antiarrhythmic agent. American Heart Journal. 115(6). 1274–1279. 12 indexed citations
15.
Somberg, John C., et al.. (1987). Encainide: A new and potent antiarrhythmic. American Heart Journal. 114(4). 826–835. 5 indexed citations
16.
Tepper, David, et al.. (1987). Evaluation of Dosing Interval and Optimum Dose of Cibenzoline. The Journal of Clinical Pharmacology. 27(9). 666–672. 3 indexed citations
17.
Torres, Vilma, David Tepper, David Flowers, et al.. (1986). QT prolongation and the antiarrhythmic efficacy of amiodarone. Journal of the American College of Cardiology. 7(1). 142–147. 70 indexed citations
18.
Somberg, John C., Vilma Torres, David Tepper, et al.. (1985). Therapy for Late Post Infarction Ventricular Tachycardia. Angiology. 36(3). 181–190. 1 indexed citations
19.
Keren, Gad, David Tepper, William Maguire, et al.. (1984). Studies on the possible mechanisms of lidoflazine arrhythmogenicity. Journal of the American College of Cardiology. 4(4). 742–747. 10 indexed citations
20.
Tepper, David, et al.. (1983). Effects of Amrinone on Atrioventricular Conduction in the Intact Canine Heart. The Journal of Clinical Pharmacology. 23(7). 257–265. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Lee Lewandrowski Breakdown of academic impact, for papers by AJ Camm Breakdown of academic impact, for papers by G. Frangin Breakdown of academic impact, for papers by P D Batin Breakdown of academic impact, for papers by J. S. Alpert Breakdown of academic impact, for papers by J Benotti Breakdown of academic impact, for papers by Joan G. Meeder Breakdown of academic impact, for papers by D G Julian Breakdown of academic impact, for papers by C. Torp‐Pedersen Breakdown of academic impact, for papers by J. R. Hampton
Rankless by CCL
2026